Literature DB >> 18599224

Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?

Gen Kanayama1, James I Hudson, Harrison G Pope.   

Abstract

BACKGROUND: The problem of anabolic-androgenic steroid (AAS) abuse has recently generated widespread public and media attention. Most AAS abusers, however, are not elite athletes like those portrayed in the media, and many are not competitive athletes at all. This larger but less visible population of ordinary AAS users began to emerge in about 1980. The senior members of this population are now entering middle age; they represent the leading wave of a new type of aging former substance abusers, with specific medical and psychiatric risks.
METHODS: We reviewed the evolving literature on long-term psychiatric and medical consequences of AAS abuse.
RESULTS: Long-term use of supraphysiologic doses of AAS may cause irreversible cardiovascular toxicity, especially atherosclerotic effects and cardiomyopathy. In other organ systems, evidence of persistent toxicity is more modest, and interestingly, there is little evidence for an increased risk of prostate cancer. High concentrations of AAS, comparable to those likely sustained by many AAS abusers, produce apoptotic effects on various cell types, including neuronal cells--raising the specter of possibly irreversible neuropsychiatric toxicity. Finally, AAS abuse appears to be associated with a range of potentially prolonged psychiatric effects, including dependence syndromes, mood syndromes, and progression to other forms of substance abuse. However, the prevalence and severity of these various effects remains poorly understood.
CONCLUSIONS: As the first large wave of former AAS users now moves into middle age, it will be important to obtain more systematic data on the long-term psychiatric and medical consequences of this form of substance abuse.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18599224      PMCID: PMC2646607          DOI: 10.1016/j.drugalcdep.2008.05.004

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  166 in total

1.  Effects of anabolic-androgenic steroids on weight-lifters' myocardium: an ultrasonic videodensitometric study.

Authors:  V Di Bello; D Giorgi; M Bianchi; A Bertini; M T Caputo; G Valenti; O Furioso; L Alessandri; M Paterni; C Giusti
Journal:  Med Sci Sports Exerc       Date:  1999-04       Impact factor: 5.411

Review 2.  Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders.

Authors:  Vittorio Fineschi; Irene Riezzo; Fabio Centini; Enrico Silingardi; Manuela Licata; Giovanni Beduschi; Steven B Karch
Journal:  Int J Legal Med       Date:  2005-11-15       Impact factor: 2.686

3.  Hepatic angiosarcoma associated with androgenic-anabolic steroids.

Authors:  T K Daneshmend; J W Bradfield
Journal:  Lancet       Date:  1979-12-08       Impact factor: 79.321

4.  Anabolic androgenic steroids and suicide.

Authors:  K J Brower; F C Blow; G A Eliopulos; T P Beresford
Journal:  Am J Psychiatry       Date:  1989-08       Impact factor: 18.112

5.  Anorexia nervosa and "reverse anorexia" among 108 male bodybuilders.

Authors:  H G Pope; D L Katz; J I Hudson
Journal:  Compr Psychiatry       Date:  1993 Nov-Dec       Impact factor: 3.735

6.  Reversible hypogonadism and azoospermia as a result of anabolic-androgenic steroid use in a bodybuilder with personality disorder. A case report.

Authors:  N P Boyadjiev; K N Georgieva; R I Massaldjieva; S I Gueorguiev
Journal:  J Sports Med Phys Fitness       Date:  2000-09       Impact factor: 1.637

Review 7.  Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions.

Authors:  Isela Velazquez; Blanche P Alter
Journal:  Am J Hematol       Date:  2004-11       Impact factor: 10.047

8.  Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?

Authors:  A Urhausen; T Albers; W Kindermann
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

9.  Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids.

Authors:  R D Dickerman; F Schaller; I Prather; W J McConathy
Journal:  Cardiology       Date:  1995       Impact factor: 1.869

10.  Anabolic steroid use among students at a British college of technology.

Authors:  D J Williamson
Journal:  Br J Sports Med       Date:  1993-09       Impact factor: 13.800

View more
  86 in total

1.  Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouse.

Authors:  Beth A Costine; Joseph G Oberlander; Matthew C Davis; Carlos A A Penatti; Donna M Porter; Robert N Leaton; Leslie P Henderson
Journal:  Psychoneuroendocrinology       Date:  2010-05-26       Impact factor: 4.905

2.  Culture, psychosomatics and substance abuse: the example of body image drugs.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Psychother Psychosom       Date:  2012-01-18       Impact factor: 17.659

3.  Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study.

Authors:  Harrison G Pope; Gen Kanayama; James I Hudson
Journal:  Biol Psychiatry       Date:  2011-08-12       Impact factor: 13.382

Review 4.  Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors.

Authors:  Marie M Onakomaiya; Leslie P Henderson
Journal:  Psychopharmacology (Berl)       Date:  2016-01-12       Impact factor: 4.530

5.  Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2009-04-01       Impact factor: 4.492

6.  Development and validation of the appearance and performance enhancing drug use schedule.

Authors:  Tom Hildebrandt; James W Langenbucher; Justine Karmin Lai; Katharine L Loeb; Eric Hollander
Journal:  Addict Behav       Date:  2011-05-11       Impact factor: 3.913

7.  Testosterone regulates bone response to inflammation.

Authors:  J P Steffens; B S Herrera; L S Coimbra; D N Stephens; C Rossa; L C Spolidorio; A Kantarci; T E Van Dyke
Journal:  Horm Metab Res       Date:  2014-02-13       Impact factor: 2.936

8.  Psychosocial correlates of gap time to anabolic-androgenic steroid use.

Authors:  Patrycja Klimek; Tom Hildebrandt
Journal:  Int J Eat Disord       Date:  2018-03-15       Impact factor: 4.861

9.  Cognitive deficits in long-term anabolic-androgenic steroid users.

Authors:  Gen Kanayama; Joseph Kean; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2012-12-14       Impact factor: 4.492

10.  Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids.

Authors:  Nawed Deshmukh; Andrea Petróczi; James Barker; Andrea D Székely; Iltaf Hussain; Declan P Naughton
Journal:  Subst Abuse Treat Prev Policy       Date:  2010-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.